Key facts
- Oxbridge Clinical’s last known valuation is $22.5M (Oct 2025).
- It has raised $5.5M across 1 recorded rounds; the latest was Seed Round ($4.5M) in Oct 2025.
- Notable investors include The Engine, Accelerate Cambridge, BioTools Innovator, Steele Foundation for Hope.
- Status: Privately Held (backing).
- ·Post-money valuations for all 1 rounds
- ·The complete investor list — 4 names
- ·Watchlist + deal alerts for Oxbridge Clinical
Funding rounds
1 roundsAbout Oxbridge Clinical
Manufacturer of diagnostic equipment designed for the identification of pathogens across a variety of sample types. The company's technology uses solid-state nanopores to differentiate among various germs that cause respiratory infections, which often present with similar symptoms, enabling healthcare professionals at the point of care to obtain rapid, cost-effective, and specific diagnoses.
- Sector
- Healthcare
- HQ
- Boston, MA, United States
- Founded
- 2023
- Employees
- 2
- Website
- oxbridgeclinical.com/
- Ownership
- Privately Held (backing)
Oxbridge Clinical doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Oxbridge Clinical shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Oxbridge Clinical in its N-PORT filings yet. We sweep new filings monthly.